Literature DB >> 2173683

In vivo and in vitro collagenolytic activity of Acanthamoeba castellanii.

Y G He1, J Y Niederkorn, J P McCulley, G L Stewart, D R Meyer, R Silvany, J Dougherty.   

Abstract

Axenic cultures of Acanthamoeba castellanii contained a collagenolytic enzyme that digested collagen shields and purified collagen in vitro. Specificity of biologic activity was determined by the addition of selected enzyme inhibitors to the assays and revealed that the parasite-conditioned medium contained both collagenase and lower concentrations of other proteolytic enzymes. However, most of the collagenolytic and pathogenic activity was directly attributable to specific collagenase. Intrastromal injection of sterile, Acanthamoeba-conditioned culture medium into naive Lewis rats produced corneal lesions clinically similar to and closely resembling those found in biopsy specimens of human patients diagnosed with acanthamoebic keratitis. Histopathologic analysis revealed moderate-to-severe neutrophil infiltration, disruption of stromal lamellae, and edema. Identical pathologic sequelae were produced by intrastromal injection of purified collagenase (25 units/ml). The pathogenicity of the soluble parasite-derived product was removed by passage over affinity columns armed with antibody specific for collagenase. These results indicated that soluble parasite-derived factors were capable of producing lesions characteristic of acanthamoebic keratitis and that the pathogenicity of these factors was either directly or indirectly attributable to specific collagenase activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173683

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  20 in total

Review 1.  The immunobiology of Acanthamoeba keratitis.

Authors:  J Y Niederkorn; H Alizadeh; H F Leher; J P McCulley
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Pathogenesis of acanthamoebic keratitis: hypothesis based on a histological analysis of 30 cases.

Authors:  A Garner
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

3.  Exacerbation of Acanthamoeba keratitis in animals treated with anti-macrophage inflammatory protein 2 or antineutrophil antibodies.

Authors:  M Hurt; S Apte; H Leher; K Howard; J Niederkorn; H Alizadeh
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Characterisation and differentiation of pathogenic and non-pathogenic Acanthamoeba strains by their protein and antigen profiles.

Authors:  J Walochnik; K Sommer; A Obwaller; E-M Haller-Schober; H Aspöck
Journal:  Parasitol Res       Date:  2004-01-13       Impact factor: 2.289

5.  Modulation of corneal and stromal matrix metalloproteinase by the mannose-induced Acanthamoeba cytolytic protein.

Authors:  Hassan Alizadeh; Haochuan Li; Sudha Neelam; Jerry Y Niederkorn
Journal:  Exp Eye Res       Date:  2008-06-25       Impact factor: 3.467

6.  Pathogenic Acanthamoeba spp secrete a mannose-induced cytolytic protein that correlates with the ability to cause disease.

Authors:  Michael Hurt; Sudha Neelam; Jerry Niederkorn; Hassan Alizadeh
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

7.  Degradation of immunoglobulins, protease inhibitors and interleukin-1 by a secretory proteinase of Acanthamoeba castellanii.

Authors:  Byoung-Kuk Na; Jung-Hwa Cho; Chul-Yong Song; Tong-Soo Kim
Journal:  Korean J Parasitol       Date:  2002-06       Impact factor: 1.341

8.  Inhibition of Acanthamoeba species by Pseudomonas aeruginosa: rationale for their selective exclusion in corneal ulcers and contact lens care systems.

Authors:  M N Qureshi; A A Perez; R M Madayag; E J Bottone
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

Review 9.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

10.  ADP and other metabolites released from Acanthamoeba castellanii lead to human monocytic cell death through apoptosis and stimulate the secretion of proinflammatory cytokines.

Authors:  A Mattana; V Cappai; L Alberti; C Serra; P L Fiori; P Cappuccinelli
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.